Unveiling the Frontiers of Neuroscience and Biopsychiatry: Meet Our Research Laboratory

The Delta State University (DELSU) Joint Canada-Israel Neuroscience and Biopsychiatry Laboratory, established with the approval of the Vice Chancellor Prof. Egwunyenga O. Andy, is domiciled at the Department of Pharmacology, Faculty of Basic Medical Sciences, College of Health Sciences, Campus 3, Delta State University, Abraka. The laboratory was approved following the successful award of the Joint Canada-Israel Health Research Project in 2022. Our primary research focus encompasses neuroscience-based experiments, including behavioural studies and biochemical and molecular assays. However, the laboratory is equipped to undertake a wide range of research methodologies. Our investigations at the DELSU Joint Canada-Israel Neuroscience and Biopsychiatry Laboratory aim to elucidate the impact of epigenetic factors on brain development in health and disease states. Specifically, we are elucidating how neuronal and cellular changes and neuroinflammatory-related mechanisms, notably changes in microglia functions, impact development, aging, and disease states, particularly in the context of neuropsychiatric conditions. In line with this, we are always seeking to improve our technical skill sets.